Alfred Lumsdaine

“And when we think about just how the year has played out, AJ, obviously it hasn't been exactly to plan, right? I think if you look across the hospital space, volumes have been softer at the bottom of the funnel than anybody expected.”

“We reported third quarter revenue of $1.62 billion and adjusted EBITDA of $138 million, driven by strong execution and cost discipline. I'm very pleased with this performance, which reflects significant progress against a number of key initiatives as we continue to focus on controlling the controllables.”

“But I think you're thinking about it in the right framework, that it is a multi-year strategy, multi-year cycle. and, candidly, just the resource intensity to actually go through this and the potential disruption in the market.”

“I'm very pleased with how our team responded to a challenging volume environment in the second quarter. Surgeries were down materially in April and May before rebounding with modest growth in June.”

“But the company went public two years ago and is still a controlled public company. But off of that IPO, plan, three-part growth strategy. We focused, I'd say, first and foremost on expanding margins.”